Dr.Ian Chau – Best Costs, Reviews – Book Your Consultation

Professional Experience

• Consultant Medical Oncologist, Gastrointestinal & Lymphoma Units, The Royal Marsden
• Professor / Reader at Institute of Cancer Research (ICR), contributing to academic and clinical leadership
• Lead or co-investigator in many Phase I, II, III clinical trials in GI oncology
• Member of national/international committees for clinical trial design in GI and lymphoma cancers
• Recognised early in his career: Merit Awards at ASCO GI Cancers Symposium (2004, 2005) for oncology research work

Academic Contributions

• Frequent invited speaker at international oncology conferences, especially GI / upper GI focus
• Serves on scientific program and advisory committees (e.g. ASCO GI, NCRI gastrointestinal cancer groups)
• Leads translational research that bridges laboratory biomarkers with patient treatments
• Contributes to peer review and development of novel therapy protocols and trial design

Areas of Expertise

• Gastrointestinal cancers — colorectal, oesophageal, gastric, pancreatic
• Lymphoma management in the context of medical oncology
• Biomarker-guided therapy: using molecular markers to tailor treatment
• Immunotherapy combinations and novel agents in GI cancer
• Translational research integration: applying research discoveries to patient care

Publications and Research

Professor Chau has published extensively in high-impact oncology journals. His work includes:

• Clinical trials in colorectal cancer, gastric cancer, and immunotherapy combinations
• Studies on biomarker selection, tumour biology, and resistance mechanisms
• Contributions to reviews and consensus guidelines in GI oncology

His publication profile is visible on ResearchGate, showing hundreds of authored works and wide citation impact.

Patient Care Philosophy

• Emphasis on modern, evidence-based care combined with compassion and clear communication
• Patient-centric decision making: all treatment plans are individualized to patient condition, preferences, and risk/benefit balance
• Strong support for clinical trial access: offering novel therapies when standard options are limited
• Collaborative multidisciplinary care: working closely with surgeons, radiologists, pathologists and other specialists
• Openness to international referrals and remote consultations (where feasible) to extend access

Professional Affiliations

• Member / contributor, ASCO (American Society of Clinical Oncology) and ASCO GI Program committees
• Participant in NCRI (National Cancer Research Institute) GI cancer study groups
• Professor / academic appointment at Institute of Cancer Research (ICR), UK
• Fellow of the Royal College of Physicians (FRCP)

FAQs

Is Professor Ian Chau board-certified?

Yes, he holds FRCP status and is a fully qualified consultant medical oncologist in the UK.

What types of cancers does he treat?

He specializes in gastrointestinal (GI) cancers (colon, stomach, oesophageal, pancreatic) and lymphoma in the oncology setting.

Does he see international patients?

Yes, through The Royal Marsden’s referrals and private care services, he accepts international patient referrals and remote consultation when possible.

How long is the typical stay for treatment?

Most treatments are outpatient or day cases; inpatient stays depend on regimen intensity, side effects, and patient condition.

What languages does he speak?

He practices in English. (No public confirmation of additional languages.)

How can one book a consultation with him?

Consultations can be arranged via The Royal Marsden Private Care or through institutional referral channels.